More specific approaches to affect the interaction between clonal hematopoietic cells and the development of atherosclerosis could be represented an anti-inflammatory treatment affecting IL-1β or the restoration of TET2 function by vitamin C [46]. The gene discussed is TET2; the disease is atherosclerosis.